Drug susceptibility of matrix‐encapsulated Candida albicans nano‐biofilms

A Srinivasan, CM Gupta, CM Agrawal… - Biotechnology and …, 2014 - Wiley Online Library
The rise in the use of biomedical devices and implants has seen a concomitant surge in the
advent of device‐related nosocomial (hospital‐acquired) infections of bacterial and fungal …

Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins

DM Kuhn, T George, J Chandra… - Antimicrobial agents …, 2002 - Am Soc Microbiol
Biofilms, likely the predominant mode of device-related microbial infection, exhibit resistance
to antimicrobial agents. Evidence suggests that Candida biofilms have dramatically reduced …

Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicansBiofilms

G Ramage, K Vande Walle, BL Wickes… - Antimicrobial agents …, 2001 - Am Soc Microbiol
Candida albicans is implicated in many biomaterial-related infections. Typically, these
infections are associated with biofilm formation. Cells in biofilms display phenotypic traits …

Fungal biofilms and antimycotics

J Chandra, G Zhou, MA Ghannoum - Current Drug Targets, 2005 - ingentaconnect.com
Device-related infections in most nosocomial diseases can be traced to the formation of
biofilms (microbial communities encased within a polysaccharide-rich extracellular matrix) …

Techniques for Antifungal Susceptibility Testing of Candida albicans Biofilms

G Ramage, JL López-Rib - Antifungal agents: methods and protocols, 2005 - Springer
Candida albicans is capable of forming biofilms on a variety of inert and biological surfaces.
Cells in biofilms display phenotypic properties that are radically different from their free …

A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms

CG Pierce, P Uppuluri, S Tummala… - JoVE (Journal of …, 2010 - jove.com
Candida albicans remains the most frequent cause of fungal infections in an expanding
population of compromised patients and candidiasis is now the third most common infection …

In Vitro Culturing and Screening of Candida albicans Biofilms

M Gulati, MB Lohse, CL Ennis… - Current protocols in …, 2018 - Wiley Online Library
Candida albicans is a normal member of the human microbiota that asymptomatically
colonizes healthy individuals, however it is also an opportunistic pathogen that can cause …

Assessment and Optimizations of Candida albicansIn Vitro Biofilm Assays

MB Lohse, M Gulati, A Valle Arevalo… - Antimicrobial agents …, 2017 - Am Soc Microbiol
Candida albicans biofilms have a significant medical impact due to their rapid growth on
implanted medical devices, their resistance to antifungal drugs, and their ability to seed …

Biofilm Formation by the Fungal PathogenCandida albicans: Development, Architecture, and Drug Resistance

J Chandra, DM Kuhn, PK Mukherjee… - Journal of …, 2001 - Am Soc Microbiol
Biofilms are a protected niche for microorganisms, where they are safe from antibiotic
treatment and can create a source of persistent infection. Using two clinically relevant …

Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin

S Kucharíková, H Tournu, K Lagrou… - Journal of medical …, 2011 - microbiologyresearch.org
Candida biofilm development can be influenced by diverse factors such as substrate, culture
medium, carbohydrate source and pH. We have analysed biofilm formation of Candida …